tiprankstipranks
Trending News
More News >
Cypherpunk Technologies Inc. (CYPH)
NASDAQ:CYPH

Cypherpunk Technologies (CYPH) Price & Analysis

Compare
993 Followers

CYPH Stock Chart & Stats

$0.61
-$0.04(-5.38%)
--

Bulls Say, Bears Say

Bulls Say
Low Leverage / Balance Sheet FlexibilityVery low debt-to-equity (~0.7% TTM) provides durable financial flexibility to absorb operating volatility and fund strategic initiatives. This reduces short-term solvency risk and improves bargaining power for financing, supporting runway while profitability is pursued.
Strong Revenue ReboundAn 89% TTM revenue rebound signals meaningful commercial traction in the company’s privacy/security offerings. Sustained top-line growth improves the odds of achieving scale, which can enable durable margin improvement if cost structure is managed and supports a transition toward positive operating leverage.
Strategic Crypto Treasury AccumulationAggressive accumulation of Zcash establishes a tangible crypto asset reserve aligned with Cypherpunk’s privacy focus. A sizable, strategic holding can diversify the balance sheet, provide long-term upside or liquidity optionality, and support differentiated positioning and network influence in privacy technologies.
Bears Say
Sustained Cash BurnPersistent negative operating and free cash flow (~-$61M and -$63M TTM) indicates ongoing cash burn that will require external financing or asset monetization. This structural cash deficit constrains investment capacity and increases dilution risk unless operating cash conversion materially improves.
Deeply Negative Margins & Large Net LossDeeply negative gross profit and a roughly -$98M net loss reflect a cost base that currently outpaces revenue, indicating margins are not sustainable. Structural margin deficits erode shareholder returns and necessitate meaningful execution on cost control or higher revenue quality to reach durable profitability.
Dilution And Governance/capital-structure RiskRecent governance and financing actions (share-authority increases, equity plan, private placement proposal, reverse split and warrant modifications) expand capacity to raise equity and indicate likely dilution. Combined with consultant RSUs and board appointments, these structural changes heighten long-term shareholder dilution and governance risk.

Cypherpunk Technologies News

CYPH FAQ

What was Cypherpunk Technologies Inc.’s price range in the past 12 months?
Cypherpunk Technologies Inc. lowest stock price was $0.22 and its highest was $3.70 in the past 12 months.
    What is Cypherpunk Technologies Inc.’s market cap?
    Cypherpunk Technologies Inc.’s market cap is $34.86M.
      When is Cypherpunk Technologies Inc.’s upcoming earnings report date?
      Cypherpunk Technologies Inc.’s upcoming earnings report date is Mar 23, 2026 which is in 18 days.
        How were Cypherpunk Technologies Inc.’s earnings last quarter?
        Cypherpunk Technologies Inc. released its earnings results on Nov 12, 2025. The company reported -$0.08 earnings per share for the quarter, beating the consensus estimate of -$0.24 by $0.16.
          Is Cypherpunk Technologies Inc. overvalued?
          According to Wall Street analysts Cypherpunk Technologies Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Cypherpunk Technologies Inc. pay dividends?
            Cypherpunk Technologies Inc. does not currently pay dividends.
            What is Cypherpunk Technologies Inc.’s EPS estimate?
            Cypherpunk Technologies Inc.’s EPS estimate is -0.07.
              How many shares outstanding does Cypherpunk Technologies Inc. have?
              Cypherpunk Technologies Inc. has 56,651,840 shares outstanding.
                What happened to Cypherpunk Technologies Inc.’s price movement after its last earnings report?
                Cypherpunk Technologies Inc. reported an EPS of -$0.08 in its last earnings report, beating expectations of -$0.24. Following the earnings report the stock price went up 369.108%.
                  Which hedge fund is a major shareholder of Cypherpunk Technologies Inc.?
                  Currently, no hedge funds are holding shares in CYPH
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Cypherpunk Technologies Stock Smart Score

                    5
                    Neutral
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10

                    Technicals

                    SMA
                    Negative
                    20 days / 200 days
                    Momentum
                    45.39%
                    12-Months-Change

                    Fundamentals

                    Return on Equity
                    -196.76%
                    Trailing 12-Months
                    Asset Growth
                    -82.48%
                    Trailing 12-Months

                    Company Description

                    Cypherpunk Technologies Inc.

                    Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. The company was incorporated in 2011 and is based in Cambridge, Massachusetts.

                    Cypherpunk Technologies (CYPH) Earnings & Revenues

                    Ownership Overview

                    1.70%3.77%3.69%87.65%
                    3.77%
                    Mutual Funds
                    3.69% Other Institutional Investors
                    87.65% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks